Ann Vasc Dis. 2024 Dec 25;17(4):447-466. doi: 10.3400/avd.ar.24-00051. Epub 2024 Sep 18.
This is an annual report indicating the number and early clinical results of annual vascular treatment performed by vascular surgeons in Japan in 2017, as analyzed by Database Management Committee (DBC) members of the Japanese Society for Vascular Surgery (JSVS). To survey the current status of vascular treatments performed by vascular surgeons in Japan, the DBC members of the JSVS analyzed the vascular treatment data provided by the National Clinical Database, including the number of treatments and early results such as operative and hospital mortality. In total, 137,909 vascular treatments were registered by 1,076 institutions in 2017. This database comprised seven fields including treatment of aneurysms, chronic arterial occlusive disease, acute arterial occlusive disease, vascular injury, complication of previous vascular reconstruction, venous diseases, and other vascular treatments. The number of vascular treatments in each field was 21,680, 18,123, 4,765 2,418, 669, 48,625, and 41,629, respectively. In the aneurysm treatment, 19,982 cases of abdominal aortic aneurysm (AAA), including common iliac aneurysm, were registered, and 64.1% were treated by endovascular aneurysm repair (EVAR). Among AAA cases, 1,824 (9.1%) cases were registered as ruptured AAA. The operative mortality rates of ruptured and unruptured AAA were 15.0%, and 0.7%, respectively. 37.9% of ruptured AAA were treated by EVAR, and the EVAR ratio was gradually increasing, but the operative mortality rates of open repair and EVAR for ruptured AAA were 14.5%, and 12.3%, respectively. There was no statistical significance. Regarding chronic arterial occlusive disease, open repair was performed in 7,277 cases, including 1,348 distal bypasses to the crural or pedal artery, whereas endovascular treatment (EVT) was performed in 9,248 cases. The EVT ratio was gradually increased at 56.0%. The number of varicose vein treatments decreased to 46,754 (11.2% less than in 2016), and 73.7% of the cases were treated by endovenous laser or radiofrequency ablations. Regarding other vascular operations, 38,769 cases of vascular access operations and 1,548 lower limb amputation surgeries were included. The number of vascular treatments increased since 2011, and the proportion of endovascular procedures increased in almost all fields of vascular diseases, especially EVAR for AAA and EVT for chronic arterial occlusive disease. (This is a translation of Jpn J Vasc Surg 2021; 30: 359-379.).
这是一份年度报告，展示了2017年日本血管外科医生进行的年度血管治疗的数量及早期临床结果，由日本血管外科学会（JSVS）数据库管理委员会（DBC）成员进行分析。为调查日本血管外科医生进行血管治疗的现状，JSVS的DBC成员分析了国家临床数据库提供的血管治疗数据，包括治疗数量以及诸如手术死亡率和医院死亡率等早期结果。2017年，1076家机构共登记了137,909例血管治疗。该数据库涵盖七个领域，包括动脉瘤治疗、慢性动脉闭塞性疾病、急性动脉闭塞性疾病、血管损伤、既往血管重建并发症、静脉疾病以及其他血管治疗。每个领域的血管治疗数量分别为21,680例、18,123例、4,765例、2,418例、669例、48,625例和41,629例。在动脉瘤治疗中，登记了19,982例腹主动脉瘤（AAA）病例，包括髂总动脉瘤，其中64.1%通过血管腔内动脉瘤修复术（EVAR）进行治疗。在AAA病例中，1824例（9.1%）被登记为破裂性AAA。破裂性和非破裂性AAA的手术死亡率分别为15.0%和0.7%。37.9%的破裂性AAA通过EVAR进行治疗，且EVAR比例逐渐上升，但破裂性AAA开放修复和EVAR的手术死亡率分别为14.5%和12.3%。两者无统计学意义。关于慢性动脉闭塞性疾病，7277例进行了开放修复，其中1348例为下肢或足部动脉远端旁路移植术，而9248例进行了血管腔内治疗（EVT）。EVT比例逐渐上升至56.0%。静脉曲张治疗数量降至46,754例（比2016年减少11.2%），73.7%的病例通过静脉内激光或射频消融治疗。关于其他血管手术，包括38,769例血管通路手术和1548例下肢截肢手术。自2011年以来，血管治疗数量增加，血管腔内手术的比例在几乎所有血管疾病领域都有所上升，尤其是AAA的EVAR和慢性动脉闭塞性疾病的EVT。（本文翻译自《日本血管外科学杂志》2021年；30: 359 - 379。）
